Skip to main content
OpenTrials

Clinical trial condition

Primary Immune Thrombocytopenia

Explore clinical trials studying Primary Immune Thrombocytopenia. Study availability and eligibility vary by location and protocol.

27 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Primary Immune Thrombocytopenia trial results

Recruiting

A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

NCT07700238

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • MemorialCare Long Beach Medical Center Long Beach, California, United States
  • The Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Hematology Oncology Associates of Fredericksburg Fredericksburg, Virginia, United States
View Trial Details
Recruiting

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

NCT07710248

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Pingdingshan First People's Hospital Pingdingshan, Henan, China
  • Jining No.1 People's Hospital Jining, Shandong, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View all 22 locations
View Trial Details
Recruiting

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

NCT07039422

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Roeselare, West-Vlaanderen, Belgium
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Dalian, Liaoning, China
View all 25 locations
View Trial Details
Recruiting

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

NCT05070845

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • East Carolina University Greenville, North Carolina, United States
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • South West Radiology Liverpool, New South Wales, Australia
  • Slade Pharmacy Mount Kuring-Gai, New South Wales, Australia
View all 31 locations
View Trial Details
Recruiting

A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

NCT06900920

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • The first affiliated hospital of ustc anhui provincial hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Chaoyang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 53 locations
View Trial Details

Related conditions